# EVERTEC, Inc.: financial statements, quarterly

EVTC · NYSE · CIK 1559865 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/evtc.md) · [Financials](/companies/evtc/financials.md) · [Filings](/companies/evtc/filings.md) · [Insiders](/companies/evtc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/evtc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [173](/filings/0001559865-24-000052.md) | [195 d](/filings/0001559865-26-000012.md) | [205](/filings/0001559865-25-000023.md) | [212](/filings/0001559865-25-000032.md) | [212](/filings/0001559865-25-000054.md) | [216 d](/filings/0001559865-26-000012.md) | [229](/filings/0001559865-26-000030.md) | [230](/filings/0001559865-26-000047.md) | [229](/filings/0001559865-25-000054.md) | [245 d](/filings/0001559865-26-000012.md) | [248](/filings/0001559865-26-000030.md) | [275](/filings/0001559865-26-000047.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [30.4](/filings/0001559865-24-000052.md) | [44.3 d](/filings/0001559865-26-000012.md) | [35.6](/filings/0001559865-25-000023.md) | [38.2](/filings/0001559865-25-000032.md) | [34.1](/filings/0001559865-25-000054.md) | [37.6 d](/filings/0001559865-26-000012.md) | [36.2](/filings/0001559865-26-000030.md) | [35.1](/filings/0001559865-26-000047.md) | [37.7](/filings/0001559865-25-000054.md) | [45.2 d](/filings/0001559865-26-000012.md) | [47.8](/filings/0001559865-26-000030.md) | [57.3](/filings/0001559865-26-000047.md) |
| Operating income | $m | [39.6](/filings/0001559865-24-000052.md) | [21.7 d](/filings/0001559865-26-000012.md) | [32.8](/filings/0001559865-25-000023.md) | [43.4](/filings/0001559865-25-000032.md) | [41.5](/filings/0001559865-25-000054.md) | [48.0 d](/filings/0001559865-26-000012.md) | [49.5](/filings/0001559865-26-000030.md) | [56.1](/filings/0001559865-26-000047.md) | [37.7](/filings/0001559865-25-000054.md) | [43.1 d](/filings/0001559865-26-000012.md) | [44.6](/filings/0001559865-26-000030.md) | [53.3](/filings/0001559865-26-000047.md) |
| Interest expense | $m | [5.7](/filings/0001559865-23-000043.md) | [15.3 d](/filings/0001559865-24-000008.md) | [19.9](/filings/0001559865-24-000027.md) | [18.7](/filings/0001559865-25-000032.md) | [18.7](/filings/0001559865-25-000054.md) | [17.4 d](/filings/0001559865-26-000012.md) | [17.0](/filings/0001559865-26-000030.md) | [16.7](/filings/0001559865-26-000047.md) | [16.5](/filings/0001559865-25-000054.md) | [18.0 d](/filings/0001559865-26-000012.md) | [17.4](/filings/0001559865-26-000030.md) | [20.3](/filings/0001559865-26-000047.md) |
| Income tax | $m | [(4.9)](/filings/0001559865-24-000052.md) | [0.9 d](/filings/0001559865-26-000012.md) | [0.3](/filings/0001559865-25-000023.md) | [1.1](/filings/0001559865-25-000032.md) | [1.7](/filings/0001559865-25-000054.md) | [1.7 d](/filings/0001559865-26-000012.md) | [4.1](/filings/0001559865-26-000030.md) | [4.1](/filings/0001559865-26-000047.md) | [(0.0)](/filings/0001559865-25-000054.md) | [1.6 d](/filings/0001559865-26-000012.md) | [4.2](/filings/0001559865-26-000030.md) | [20.3](/filings/0001559865-26-000047.md) |
| Net income | $m | [10.0](/filings/0001559865-24-000052.md) | [11.5 d](/filings/0001559865-26-000012.md) | [16.0](/filings/0001559865-25-000023.md) | [31.9](/filings/0001559865-25-000032.md) | [24.7](/filings/0001559865-25-000054.md) | [40.1 d](/filings/0001559865-26-000012.md) | [32.7](/filings/0001559865-26-000030.md) | [40.5](/filings/0001559865-26-000047.md) | [32.9](/filings/0001559865-25-000054.md) | [35.6 d](/filings/0001559865-26-000012.md) | [23.8](/filings/0001559865-26-000030.md) | [5.4](/filings/0001559865-26-000047.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001559865-24-000052.md) | not reported | [0.24](/filings/0001559865-25-000023.md) | [0.49](/filings/0001559865-25-000032.md) | [0.38](/filings/0001559865-25-000054.md) | not reported | [0.50](/filings/0001559865-26-000030.md) | [0.62](/filings/0001559865-26-000047.md) | [0.51](/filings/0001559865-25-000054.md) | not reported | [0.38](/filings/0001559865-26-000030.md) | [0.09](/filings/0001559865-26-000047.md) |
| Basic EPS | $ per share | [0.16](/filings/0001559865-24-000052.md) | not reported | [0.25](/filings/0001559865-25-000023.md) | [0.50](/filings/0001559865-25-000032.md) | [0.39](/filings/0001559865-25-000054.md) | not reported | [0.51](/filings/0001559865-26-000030.md) | [0.63](/filings/0001559865-26-000047.md) | [0.51](/filings/0001559865-25-000054.md) | not reported | [0.38](/filings/0001559865-26-000030.md) | [0.09](/filings/0001559865-26-000047.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [178](/filings/0001559865-24-000052.md) | [296](/filings/0001559865-26-000012.md) | [294](/filings/0001559865-25-000023.md) | [258](/filings/0001559865-25-000032.md) | [275](/filings/0001559865-25-000054.md) | [274](/filings/0001559865-26-000012.md) | [266](/filings/0001559865-26-000030.md) | [291](/filings/0001559865-26-000047.md) | [475](/filings/0001559865-25-000054.md) | [306](/filings/0001559865-26-000047.md) | [291](/filings/0001559865-26-000030.md) | [261](/filings/0001559865-26-000047.md) |
| Current assets | $m | [402](/filings/0001559865-23-000043.md) | [561](/filings/0001559865-25-000007.md) | [563](/filings/0001559865-24-000027.md) | [531](/filings/0001559865-24-000044.md) | [534](/filings/0001559865-24-000052.md) | [529](/filings/0001559865-26-000012.md) | [555](/filings/0001559865-25-000023.md) | [571](/filings/0001559865-25-000032.md) | [744](/filings/0001559865-25-000054.md) | [591](/filings/0001559865-26-000047.md) | [602](/filings/0001559865-26-000030.md) | [586](/filings/0001559865-26-000047.md) |
| Total assets | $m | [1,221](/filings/0001559865-23-000043.md) | [2,060](/filings/0001559865-25-000007.md) | [1,996](/filings/0001559865-24-000027.md) | [1,890](/filings/0001559865-24-000044.md) | [1,895](/filings/0001559865-24-000052.md) | [1,858](/filings/0001559865-26-000012.md) | [1,918](/filings/0001559865-25-000023.md) | [1,961](/filings/0001559865-25-000032.md) | [2,149](/filings/0001559865-25-000054.md) | [2,243](/filings/0001559865-26-000047.md) | [2,296](/filings/0001559865-26-000030.md) | [2,480](/filings/0001559865-26-000047.md) |
| Current liabilities | $m | [249](/filings/0001559865-23-000043.md) | [298](/filings/0001559865-25-000007.md) | [354](/filings/0001559865-24-000027.md) | [291](/filings/0001559865-24-000044.md) | [270](/filings/0001559865-24-000052.md) | [280](/filings/0001559865-26-000012.md) | [280](/filings/0001559865-25-000023.md) | [260](/filings/0001559865-25-000032.md) | [256](/filings/0001559865-25-000054.md) | [285](/filings/0001559865-26-000047.md) | [306](/filings/0001559865-26-000030.md) | [344](/filings/0001559865-26-000047.md) |
| Total liabilities | $m | [685](/filings/0001559865-23-000043.md) | [1,425](/filings/0001559865-25-000007.md) | [1,445](/filings/0001559865-24-000027.md) | [1,364](/filings/0001559865-24-000044.md) | [1,349](/filings/0001559865-24-000052.md) | [1,338](/filings/0001559865-26-000012.md) | [1,332](/filings/0001559865-25-000023.md) | [1,305](/filings/0001559865-25-000032.md) | [1,441](/filings/0001559865-25-000054.md) | [1,529](/filings/0001559865-26-000047.md) | [1,530](/filings/0001559865-26-000030.md) | [1,761](/filings/0001559865-26-000047.md) |
| Long-term debt | $m | [375](/filings/0001559865-23-000043.md) | [947](/filings/0001559865-25-000007.md) | [942](/filings/0001559865-24-000027.md) | [936](/filings/0001559865-24-000044.md) | [931](/filings/0001559865-24-000052.md) | [925](/filings/0001559865-26-000012.md) | [920](/filings/0001559865-25-000023.md) | [915](/filings/0001559865-25-000032.md) | [1,059](/filings/0001559865-25-000054.md) | [1,053](/filings/0001559865-26-000047.md) | [1,045](/filings/0001559865-26-000030.md) | [1,222](/filings/0001559865-26-000047.md) |
| Current portion of debt | $m | [20.8](/filings/0001559865-23-000043.md) | [23.9](/filings/0001559865-25-000007.md) | [23.9](/filings/0001559865-24-000027.md) | [23.9](/filings/0001559865-24-000044.md) | [23.9](/filings/0001559865-24-000052.md) | [23.9](/filings/0001559865-26-000012.md) | [23.9](/filings/0001559865-25-000023.md) | [23.9](/filings/0001559865-25-000032.md) | [23.9](/filings/0001559865-25-000054.md) | [23.9](/filings/0001559865-26-000047.md) | [26.9](/filings/0001559865-26-000030.md) | [29.8](/filings/0001559865-26-000047.md) |
| Short-term borrowings | $m | [6.0](/filings/0001559865-23-000043.md) | [0.0](/filings/0001559865-24-000027.md) | [80.0](/filings/0001559865-24-000027.md) | not reported | not reported | [0.0](/filings/0001559865-26-000012.md) | not reported | not reported | not reported | [10.0](/filings/0001559865-26-000047.md) | [25.0](/filings/0001559865-26-000030.md) | [35.0](/filings/0001559865-26-000047.md) |
| Shareholders' equity | $m | [532](/filings/0001559865-23-000043.md) | [594](/filings/0001559865-25-000007.md) | [507](/filings/0001559865-24-000027.md) | [483](/filings/0001559865-24-000044.md) | [503](/filings/0001559865-24-000052.md) | [473](/filings/0001559865-26-000012.md) | [542](/filings/0001559865-25-000023.md) | [612](/filings/0001559865-25-000032.md) | [664](/filings/0001559865-25-000054.md) | [622](/filings/0001559865-26-000047.md) | [668](/filings/0001559865-26-000030.md) | [641](/filings/0001559865-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [37.6 d](/filings/0001559865-24-000052.md) | [52.9 d](/filings/0001559865-26-000012.md) | [40.7](/filings/0001559865-25-000023.md) | [90.6 d](/filings/0001559865-25-000032.md) | [53.6 d](/filings/0001559865-25-000054.md) | [75.2 d](/filings/0001559865-26-000012.md) | [37.6](/filings/0001559865-26-000030.md) | [48.5 d](/filings/0001559865-26-000047.md) | [70.9 d](/filings/0001559865-25-000054.md) | [70.0 d](/filings/0001559865-26-000012.md) | [31.2](/filings/0001559865-26-000030.md) | [59.5 d](/filings/0001559865-26-000047.md) |
| Capital expenditure | $m | [5.1 d](/filings/0001559865-24-000052.md) | [5.0 d](/filings/0001559865-26-000012.md) | [5.4](/filings/0001559865-25-000023.md) | [11.8 d](/filings/0001559865-25-000032.md) | [3.8 d](/filings/0001559865-25-000054.md) | [4.3 d](/filings/0001559865-26-000012.md) | [6.4](/filings/0001559865-26-000030.md) | [5.0 d](/filings/0001559865-26-000047.md) | [5.6 d](/filings/0001559865-25-000054.md) | [6.3 d](/filings/0001559865-26-000012.md) | [6.3](/filings/0001559865-26-000030.md) | [4.9 d](/filings/0001559865-26-000047.md) |
| Dividends paid | $m | [3.2 d](/filings/0001559865-24-000052.md) | [3.3 d](/filings/0001559865-26-000012.md) | [3.3](/filings/0001559865-25-000023.md) | [3.2 d](/filings/0001559865-25-000032.md) | [3.2 d](/filings/0001559865-25-000054.md) | [3.2 d](/filings/0001559865-26-000012.md) | [3.2](/filings/0001559865-26-000030.md) | [3.2 d](/filings/0001559865-26-000047.md) | [3.2 d](/filings/0001559865-25-000054.md) | [3.2 d](/filings/0001559865-26-000012.md) | [3.1](/filings/0001559865-26-000030.md) | [3.0 d](/filings/0001559865-26-000047.md) |
| Share repurchases | $m | [7.8 d](/filings/0001559865-24-000052.md) | [12.5 d](/filings/0001559865-26-000012.md) | [70.0](/filings/0001559865-25-000023.md) | [0.0 d](/filings/0001559865-25-000032.md) | [12.3 d](/filings/0001559865-25-000054.md) | [0.0 d](/filings/0001559865-26-000012.md) | [0.0](/filings/0001559865-26-000030.md) | [3.7 d](/filings/0001559865-26-000047.md) | [0.0 d](/filings/0001559865-25-000054.md) | [65.6 d](/filings/0001559865-26-000012.md) | [20.0](/filings/0001559865-26-000030.md) | [47.0 d](/filings/0001559865-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.0](/filings/0001559865-23-000043.md) | [65.6](/filings/0001559865-24-000027.md) | [65.5](/filings/0001559865-24-000044.md) | [65.8](/filings/0001559865-24-000052.md) | [66.3](/filings/0001559865-25-000023.md) | [65.2](/filings/0001559865-25-000032.md) | [64.7](/filings/0001559865-25-000054.md) | [64.8](/filings/0001559865-26-000030.md) | [64.9](/filings/0001559865-26-000047.md) | [64.8](/filings/0001559865-25-000054.md) | [62.6](/filings/0001559865-26-000030.md) | [61.4](/filings/0001559865-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,752,542 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001559865-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.